Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Cost-utility analysis of the National truth campaign to prevent youth smoking.

Holtgrave DR, Wunderink KA, Vallone DM, Healton CG.

Am J Prev Med. 2009 May;36(5):385-8. doi: 10.1016/j.amepre.2009.01.020. Epub 2009 Feb 11.

PMID:
19211214
2.
3.

Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

Bereza BG, Machado M, Einarson TR.

Clin Ther. 2009 Jun;31(6):1279-308. doi: 10.1016/j.clinthera.2009.06.004. Review.

PMID:
19695395
4.

[Literature review of health care costs of diseases attributable to tobacco consumption in the Americas].

Reynales-Shigematsu LM.

Salud Publica Mex. 2006;48 Suppl 1:S190-200. Review. Spanish.

5.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

PMID:
19817595
6.

An improved set of standards for finding cost for cost-effectiveness analysis.

Barnett PG.

Med Care. 2009 Jul;47(7 Suppl 1):S82-8. doi: 10.1097/MLR.0b013e31819e1f3f. Review.

PMID:
19536018
7.

Using a cost-benefit analysis to estimate outcomes of a clinical treatment guideline: testing theBrain Trauma Foundation guidelines for the treatment of severe traumatic brain injury.

Faul M, Wald MM, Rutland-Brown W, Sullivent EE, Sattin RW.

J Trauma. 2007 Dec;63(6):1271-8. doi: 10.1097/TA.0b013e3181493080. Review.

PMID:
18212649
8.

Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?

Menzin J, Lines LM, Marton J.

Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):257-64. doi: 10.1586/erp.09.28. Review.

PMID:
19527098
9.

Hypertension, a health economics perspective.

Alcocer L, Cueto L.

Ther Adv Cardiovasc Dis. 2008 Jun;2(3):147-55. doi: 10.1177/1753944708090572. Review.

PMID:
19124418
10.

Cost-effectiveness analysis: what it really means for transfusion medicine decision making.

Custer B, Hoch JS.

Transfus Med Rev. 2009 Jan;23(1):1-12. doi: 10.1016/j.tmrv.2008.09.001. Review.

PMID:
19056030
11.

[Practical guides for stopping the tobacco habit: a cost-effectiveness analysis?].

Pérez Trullén A, Sánchez Agudo L.

Arch Bronconeumol. 1999 May;35 Suppl 3:89-94. Review. Spanish. No abstract available.

PMID:
10410233
12.

Corporate smoking policies: a review and an analysis.

Walsh DC.

J Occup Med. 1984 Jan;26(1):17-22. Review. No abstract available.

PMID:
6420527
13.

Utilizing chair cost to evaluate the health plan contracts.

Kraupa GW.

Optometry. 2008 Aug;79(8):475-7. Review. No abstract available.

PMID:
18714476
14.

Biobanks: instrumentation, personnel and cost analysis.

Barbareschi M, Cotrupi S, Guarrera GM.

Pathologica. 2008 Apr;100(2):139-48. Review. English, Italian. No abstract available.

PMID:
18792526

Supplemental Content

Support Center